WESPAC Advisors’s GSK GSK Stock Holding History

WESPAC Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Hold	3,823	–	–	0.1%	190
2026 Q1	$211K	Buy	+3,823	New	+$207K	0.12%	166
2020 Q2	–	Sell	-27,848	Closed	-$1.32M	–	104
2020 Q1	$1.32M	Buy	+27,848	New	+$1.49M	3.16%	13
2015 Q3	–	Sell	-16,063	Closed	-$836K	–	84
2015 Q2	$836K	Buy	+16,063	New	+$904K	0.63%	61

Other funds holding GSK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WESPAC Advisors's GSK Position: Q2 2026 in Review

WESPAC Advisors held its GSK (GSK) position steady in Q2 2026 at 3,823 shares worth $200K. The position accounts for 0.1% of the portfolio, ranked #190.

WESPAC Advisors first reported a position in GSK in Q2 2015 and has held it in 4 quarters since. The position peaked at $1.32M in Q1 2020. 698 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

WESPAC Advisors held 3,823 shares of GSK worth $200K as of Q2 2026.
WESPAC Advisors left its GSK share count unchanged in Q2 2026.
GSK made up 0.1% of WESPAC Advisors's portfolio in Q2 2026, its #190 holding.
WESPAC Advisors first reported a position in GSK in Q2 2015 and has held it in 4 quarters since.
WESPAC Advisors's GSK position peaked at $1.32M in Q1 2020.
698 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on WESPAC Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.